Biofrontera Inc. Not Doing Enough For Some Investors As Its Shares Slump 28
BFRI Stock | USD 0.90 0.09 9.09% |
Under 60% of Biofrontera's investor base is looking to short. The analysis of the overall investor sentiment regarding Biofrontera suggests that many traders are alarmed. Biofrontera's investing sentiment shows overall attitude of investors towards Biofrontera.
Biofrontera |
Unfortunately for some shareholders, the Biofrontera Inc. share price has dived 28 percent in the last thirty...
Read at simplywall.st
Biofrontera Fundamental Analysis
We analyze Biofrontera's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biofrontera using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biofrontera based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Working Capital
Working Capital Comparative Analysis
Biofrontera is currently under evaluation in working capital category among its peers. Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .
Biofrontera Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Biofrontera stock to make a market-neutral strategy. Peer analysis of Biofrontera could also be used in its relative valuation, which is a method of valuing Biofrontera by comparing valuation metrics with similar companies.
Peers
Biofrontera Related Equities
RGC | Regencell Bioscience | 5.51 | ||||
CPHI | China Pharma | 5.26 | ||||
AKAN | Akanda Corp | 2.94 | ||||
CPIX | Cumberland Pharmaceuticals | 2.19 | ||||
EVOK | Evoke Pharma | 1.37 | ||||
PRFX | Painreform | 1.09 | ||||
IXHL | Incannex Healthcare | 2.20 | ||||
SHPH | Shuttle Pharmaceuticals | 2.30 | ||||
SXTC | China SXT | 2.44 | ||||
PTPI | Petros Pharmaceuticals | 6.90 | ||||
SBFMW | Sunshine Biopharma | 19.05 | ||||
PROC | Procaps Group | 27.75 |
Complementary Tools for Biofrontera Stock analysis
When running Biofrontera's price analysis, check to measure Biofrontera's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biofrontera is operating at the current time. Most of Biofrontera's value examination focuses on studying past and present price action to predict the probability of Biofrontera's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biofrontera's price. Additionally, you may evaluate how the addition of Biofrontera to your portfolios can decrease your overall portfolio volatility.
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |